Skip to main content
Log in

The effect of repeated intravenous and oral doses of molsidomine (N-carboxy-3-morpholino-sydnonimine-ethylester) on plasma renin activity and plasma catecholamine levels in conscious dogs

  • Original Contributions
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Summary

The responses of plasma renin activity (PRA) and plasma catecholamine levels to molsidomine, administered both intravenously and orally, were investigated in conscious trained dogs.

Intravenous administration of molsidomine at increasing dosage up to 0.4 mg/kg with a constant dose interval of 4 hours did not lead to a sustained increase in PRA. By contrast, a significant increase in PRA was still present after 4 hours on administration of 0.4 mg/kg molsidomine by the oral route. This longer-lasting increase in PRA following oral administration is discussed in relation to the conversion of molsidomine to an active metabolite in the liver. A reduction of dose interval to 3 hours or less led to a marked cumulative increase in PRA.

It appears that substances acting via venous pooling lead to persistent activation of the renin angiotensin aldosterone system (RAA system), which counteracts its primary therapeutic effect. A slight increase in plasma noradrenaline levels was observed in response to repeated oral administration of 0.4 mg/kg molsidomine at a dose interval of 2 hours, indicating participation of the sympathetic nervous system in the counterregulatory process.

Zusammenfassung

Die Wirkung intravenöser und peroraler Gaben von Molsidomin auf die Plasmareninaktivität (PRA) und die Plasmakatecholaminspiegel wacher Hunde wurde untersucht.

Intravenöse Verabreichung von Molsidomin in einer Dosierung bis zu 0,4 mg/kg bei einem gleichbleibenden Dosisintervall von 4 Stunden führte zu keinem langanhaltenden Anstieg der PRA. Im Gegensatz dazu war nach peroraler Verabreichung von 0,4 mg/kg Molsidomin nach 4 Stunden die PRA noch deutlich erhöht. Der relativ stärkere Anstieg der PRA auf orale Gabe wird mit Bezugnahme auf den Abbau von Molsidomin zu einem aktiven Metaboliten in der Leber diskutiert. Verkürzung des Dosisintervalls auf 3 Stunden und weniger führte zu einem kumulativen PRA-Anstieg.

Es ist anzunehmen, daß Substanzen, die venöses Pooling verursachen, zu einer andauernden Aktivierung des Renin-Angiotensin-Aldosteron-Systems (RAA-System) führen, welche dem ursprünglichen therapeutischen Effekt entgegenwirkt. Der geringe Anstieg der Plasmanoradrenalinwerte, der nach peroraler Gabe von 0,4 mg/kg Molsidomin bei einem Dosisintervall von 2 Stunden beobachtet wurde, deutet die Mitbeteiligung des Sympathischen Nervensystems bei der Gegenregulation an.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abukhres, M. M., R. J. Ertel, B. N. Dixit, R. R. Vollmer: Role of the reninangiotensin system in the blood pressure rebound to sodium nitroprusside in the conscious rat. Europ. J. Pharmacol.58, 247–254 (1979).

    Google Scholar 

  2. Bassenge, E., J. Holtz. Hamodynamische und kardiale Wirkungen von Molsidomin beim wachen Hund. In: Molsidomin (1. Molsidomin-Symposium München 1978), Hrsg. W. Lochner, F. Bender. Urban & Schwarzenberg (Munchen-Wien-Baltimore 1979).

    Google Scholar 

  3. Benke, Th., O. Kraupp, P. Placheta, B. Stanek, G. Raberger: The effect of single and repeated doses of isosorbide dinitrate on plasma renin activity and plasma catecholamine levels in conscious dogs. Basic Res. Cardiol.75, 400–409 (1980).

    PubMed  Google Scholar 

  4. Brennan, L. A., Jr., R. L. Malvin, K. E. Jochim, D. E. Roberts: Influence of right and left atrial receptors on plasma concentrations of ADH and renin. Amer. J. Physiol.221, 273–278 (1971).

    PubMed  Google Scholar 

  5. Brown, J. J., D. L. Davies, A. F. Lever, J. I. S. Robertson, A. Verniory: The effect of acute haemorrhage in the dog and man on plasma renin concentration. J. Physiol.182, 649–663 (1966).

    PubMed  Google Scholar 

  6. Brown, T. C., J. O. Davis, C. I. Johnston: Acute response in plasma renin and aldosterone secretion to diuretics. Amer. J. Physiol.211, 437–441 (1966).

    PubMed  Google Scholar 

  7. Da Prada, M., G. Zürcher: Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sciences19, 1161–1174 (1976).

    PubMed  Google Scholar 

  8. Fiedler, V. B., J. Scholtholt: Haemodynamic Effects of Molsidomine. Arzneim.-Forsch. (Drug Res.)28, 1605–1612 (1978).

    Google Scholar 

  9. Fleck, E., J. Dirschinger, W. Rudolph: Segmentale Ventrikelwandbewegung und regionale Myokarddurchblutung unter dem Einfluß von Molsidomin bei Patienten mit koronarer Herzerkrankung. In: Molsidomin (1. Molsidomin-Symposium München 1978), Hrsg. W. Lochner, F. Bender. Urban & Schwarzenberg (München-Wien-Baltimore 1979).

    Google Scholar 

  10. Goetz, K. L., B. C. Wang, M. O. K. Hakumäki, D. C. Fater, P. G. Geer, W. D. Sundet: Cardiovascular, Renal, and Humoral Effects of Applying Local Anesthetic to the Atria of Conscious Dogs. Proc. Soc. Exp. Biol. Med.167, 101–109 (1981).

    PubMed  Google Scholar 

  11. Heinzow, B., A. Ziegler: Comparison of the Effects of Nitroglycerin Administered to Rats by Different Routes. J. Cardiovasc. Pharmacol.3, 573–580 (1981).

    PubMed  Google Scholar 

  12. Haber, E., Th. Koerner, L. B. Page, B. Kliman, A. Purnode. Application of a Radioimmunoassay for Angiotensin I to the Physiologic Measurements of Plasma Renin Activity in Normal Human Subjects. J. Clin. Endocrin.29, 1349–1355 (1969).

    Google Scholar 

  13. Higgins, J. T., Jr., J. O. Davis, J. Urquart, M. J. Olichney: Increased plasma level of renin in experimental secondary hyperaldosteronism. Amer. J. Physiol.207, 814–820 (1964).

    PubMed  Google Scholar 

  14. Holtz, J., E. Bassenge, A. Kolin: Hemodynamic and myocardial effects of long-lasting venodilation in the conscious dog: Analysis of molsidomine in comparison with nitrates. Basic Res. Cardiol.73, 469–481 (1978).

    PubMed  Google Scholar 

  15. Packer, M., J. Meller, N. Medina, M. Yushak, R. Gorlin: Determinants of Drug Response in Severe Chronic Heart Failure. 1. Activation of Vasoconstrictor Forces During Vasodilator Therapy. Circulation64, 506–514 (1981).

    PubMed  Google Scholar 

  16. Pettinger, W. A., K. Keeton: Altered Renin Release and Propranolol Potentiation of Vasodilatory Drug Hypotension. J. Clin. Invest.55, 236–243 (1975).

    PubMed  Google Scholar 

  17. Sponer, G., K. Dietmann, K. Strein, W. Bartsch: Significance of dosage interval for the development of tolerance to isosorbide-5-mononitrate in conscious dogs. IRCS Medical Science: Physiology9, 619 (1981).

    Google Scholar 

  18. Stanek, B., S. Bacher, Th. Benke, G. Raberger: The effects of isosorbide dinitrate and molsidomine on plasma renin activity (PRA) and plasma catecholamine levels (NA, A) in conscious dogs. Naunyn-Schmiedeberg's Arch. Pharmacol.311, R 43 (1980).

    Google Scholar 

  19. Stanek, B., M. Zimpfer, S. Fitzal, G. Raberger: Plasma Catecholamines, Plasma Renin Activity and Haemodynamics During Sodium Nitroprusside-Induced Hypotension and Additional Beta-Blockade with Bunitrolol. Europ. J. Clin. Pharmacol.19, 317–322 (1981).

    Google Scholar 

  20. Tanamaya, S., Y. Nakai, T. Fujita, Z. Suzuoki, Y. Imashiro, K. Masuda: Biotransformation of Molsidomine (N-Ethoxycarbonyl-3-morpholinosydnonimine), a New Anti-anginal Agent, in Rats. Xenobiotica4, 175–191 (1974).

    Google Scholar 

  21. Thadani, U., H.-L. Fung, A. C. Darke, J. O. Parker: Oral Isosorbide Dinitrate in Angina Pectoris: Comparison of Duration of Action and Dose-Response Relation During Acute and Sustained Therapy. Amer. J. Cardiol.49, 411–419 (1982).

    PubMed  Google Scholar 

  22. Tukey, J. W.: Comparing individual means in the analysis of variance. Biometrics5, 99–114 (1949).

    Google Scholar 

  23. Ueda, H., Y. Kaneko, T. Takeda, T. Ikeda, S. Yagi: Observations on the Mechanism of Renin Release by Hydralazine in Hypertensive Patients. Circulat. Res.26, Suppl. II, II—201-II—206 (1970).

    Google Scholar 

  24. Watkins, L., Jr., J. A. Burton, E. Haber, J. R. Cant, F. W. Smith, A. C. Barger: The Renin-Angiotensin-Aldosterone System in Congestive Failure in Conscious Dogs. J. clin. Invest.57, 1060–1617 (1976).

    Google Scholar 

  25. Zehr, J. E., J. A. Hasbargen, K. D. Kurz: Reflex Suppression of Renin Secretion during Distension of Cardiopulmonary Receptors in Dogs. Circulat. Res.38, 232–239 (1976).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

A preliminary report of this study has been presented at the 21st Spring Meeting of the Deutsche Pharmakologische Gesellschaft (Naunyn-Schmiedeberg's Arch. Pharmacol. 311, R 43, 1980).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bacher, S., Kraupp, O., Stanek, B. et al. The effect of repeated intravenous and oral doses of molsidomine (N-carboxy-3-morpholino-sydnonimine-ethylester) on plasma renin activity and plasma catecholamine levels in conscious dogs. Basic Res Cardiol 78, 193–202 (1983). https://doi.org/10.1007/BF01906672

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01906672

Key words

Navigation